After Morcellators Shown to Spread Cancer, Manufacturer Will Recall the Device Johnson & Johnson said on Wednesday, July 30th, that it will issue a recall for its power morcellators, after studies show that both fibroid removal and hysterectomy procedures can spread uterine cancer in patients. In April, J&J’s subsidiary Ethicon suspended sales and production of the morcellators while the US Food and Drug Administration investigated the potential for the laparoscopic devices to spread previously-undetected cancer when used in fibroid … [Read more...]
Johnson & Johnson Finalizes $2.2 Billion Personal Injury Settlement
November 11, 2013 By
Johnson & Johnson Agrees to Pay $2.2 Billion in Personal Injury Settlement, Various States Receive Settlement Money On Monday, November 4th, Johnson & Johnson agreed to pay $2.2 billion for a personal injury settlement involving off-label use of their antipsychotic, Risperdal. Now, various states are receiving settlement money. According to the original lawsuit, Johnson & Johnson and their subsidiary Janssen promoted Risperdal for off-label and unapproved uses between 1999 and 2005, such as controlling aggression in elderly … [Read more...]
New Blood Test May Be Able to Detect a Single Cancer Cell
January 12, 2011 By Leave a Comment
According to CNN, the Massachusetts General Hospital has partnered with Johnson and Johnson to help in the fight against cancer. These two medical giants are working to develop a blood test that may be able to find a single cancer cell in a person’s bloodstream. In a company statement, Johnson and Johnson researchers have devised a testing kit for oncologists to diagnose the presence of cancer cells and determine how much it has spread in the patient’s body. Alongside this research would be the development of new drug regimens to fight … [Read more...]
Johnson and Johnson Hip Implant Failure Rate Prompts Recall
August 30, 2010 By Leave a Comment
ASR XL Acetabular System Recalled For Its Excessive Failure Rate In the midst of an onslought of recalls by Johnson and Johnson, and a mere two days after the FDA issued a warning letter in which the FDA advised DePuy that two of its product are misbranded, DePuy Orthopaedics, a Johnson and Johnson company, announced a recall for the ASR XL Acetabular hip replacement system. As reported in the Wall Street Journal, the failure rate of the ASR XL is 13% compared to the average 5% failure rate. The failure rate of the ASR XL Acetabular … [Read more...]
